- Clorox press release ( NYSE: CLX ): Q2 Non-GAAP EPS of $0.98 beats by $0.32 .
- Revenue of $1.72B (+1.8% Y/Y) beats by $60M .
- The net sales increase was driven largely by favorable price mix, partially offset by lower volume. Organic sales were up 4%. The three-year average growth rate for net sales was 7%.
-
The company is updating the following elements of its fiscal year 2023 outlook:
- Net sales are now expected to be between a 2% decrease to a 1% increase (organic sales from flat to a 3% increase). This compares previously to a 4% decrease to a 2% increase (organic sales from a 3% decrease to a 3% increase).
- Diluted EPS is now expected to be between $3.20 and $3.45, or a 14% to 8% decrease, respectively. This compares previously to between $3.10 and $3.47, or a 17% to 7% decrease, respectively.
- Adjusted EPS is now expected to be between $4.05 and $4.30 vs. $4.11 consensus, or a 1% decrease to a 5% increase, respectively.
For further details see:
Clorox Non-GAAP EPS of $0.98 beats by $0.32, revenue of $1.72B beats by $60M